AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 250 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $703,831 | -20.0% | 15,304 | 0.0% | 1.18% | +21.5% |
| Q2 2023 | $879,521 | +53.3% | 15,304 | 0.0% | 0.97% | +37.5% |
| Q1 2023 | $573,900 | +39.6% | 15,304 | +4.3% | 0.70% | +75.1% |
| Q4 2022 | $411,025 | -1.2% | 14,669 | 0.0% | 0.40% | -2.9% |
| Q3 2022 | $416,000 | -13.5% | 14,669 | +6.0% | 0.41% | -7.0% |
| Q2 2022 | $481,000 | -24.6% | 13,835 | -22.1% | 0.44% | -4.1% |
| Q1 2022 | $638,000 | – | 17,760 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LAM GROUP, INC. | 130,250 | $3,649,605 | 3.75% |
| SHAKER INVESTMENTS LLC/OH | 81,287 | $2,277,662 | 1.41% |
| Mesirow Institutional Investment Management, Inc. | 374,414 | $10,491,080 | 1.38% |
| OBERWEIS ASSET MANAGEMENT INC/ | 134,000 | $3,754,680 | 0.80% |
| Portolan Capital Management | 270,791 | $7,587,564 | 0.75% |
| Hillsdale Investment Management Inc. | 172,238 | $4,826,109 | 0.41% |
| Capital Impact Advisors, LLC | 14,669 | $411,025 | 0.40% |
| Watershed Asset Management, L.L.C. | 9,555 | $267,731 | 0.34% |
| Quantedge Capital Pte Ltd | 35,153 | $984,987 | 0.33% |
| FEDERATED HERMES, INC. | 3,284,217 | $92,023,760 | 0.25% |